← FDA Drug Approvals (Drugs@FDA)

CLINDAMYCIN PHOSPHATE AND TRETINOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2015-06-12

Drug application

FDA Application #

ANDA202564

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLINDAMYCIN PHOSPHATE AND TRETINOIN

Generic name

CLINDAMYCIN PHOSPHATE AND TRETINOIN

Active ingredients

CLINDAMYCIN PHOSPHATE; TRETINOIN

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

ACTAVIS MID ATLANTIC

Manufacturer

Actavis Pharma, Inc.

First approval

2015-06-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown